ameBB0367XhoI SequenceCTC GAG ATG G and 15 more items

Virginia Commonwealth University (VCU) awarded a contract to Integrated DNA Technologies Inc. on October 5, 2026, with a cumulative value of $147.00. The contract, identified as A236_P0357463, involves the procurement of synthetic DNA sequences containing various restriction enzyme recognition sites and genetic sequences. All deliverables are directed to VCU Procurement in Virginia, with the contract comprising sixteen individual line items for DNA oligonucleotides and synthetic sequences priced between $6.05 and $16.95 per unit.

The contract encompasses the delivery of branded DNA sequence products, including variants with XhoI, SacII, LF (likely Long Fragment), RFKan and LRKan (Kanamycin-related), and RR restriction sites across multiple DNA constructs designated as BB0367, BB0443, BB0696, and related identifiers. These synthetic sequences, each ordered in quantities of one unit, are standard research-grade products typically used in molecular biology applications, including plasmid construction and genetic engineering work. The award reflects VCU's procurement of molecular biology materials in support of its research and academic mission.